These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15963078)

  • 21. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity.
    Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O
    Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic drug monitoring of tacrolimus: a moving matter.
    Manzanares C
    Therapie; 2002; 57(2):133-6. PubMed ID: 12185961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients.
    Davis GL; Nelson DR; Terrault N; Pruett TL; Schiano TD; Fletcher CV; Sapan CV; Riser LN; Li Y; Whitley RJ; Gnann JW;
    Liver Transpl; 2005 Aug; 11(8):941-9. PubMed ID: 16035063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation.
    Bahr MJ; Beckermann JG; Rifai K; Gehrmann L; Rosenau J; Klempnauer J; Strassburg CP; Manns MP
    Transplant Proc; 2005 May; 37(4):1703-4. PubMed ID: 15919437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN; Mela M; Quaglia A; Triantos CK; Thalheimer U; Leandro G; Pesci A; Raimondo ML; Dhillon AP; Rolles K; Davidson BR; Patch DW; Burroughs AK
    Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.
    Barrera-Pulido L; Aguilera-García I; Docobo-Pérez F; Alamo-Martínez JM; Pareja-Ciuró F; Nuñez-Roldán A; Gómez-Bravo MA; Bernardos-Rodríguez A
    Transplant Proc; 2008 Nov; 40(9):2949-51. PubMed ID: 19010156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.
    Charco R; Rimola A; García-Valdecasas JC; Fuster J; Fondevila C; Navasa M; Julian M; Forta V; Brunet M
    Transplant Proc; 2005 Nov; 37(9):3930-1. PubMed ID: 16386588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies.
    Cosio FG; Amer H; Grande JP; Larson TS; Stegall MD; Griffin MD
    Transplantation; 2007 Feb; 83(4):411-6. PubMed ID: 17318073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cross-sectional study of SEN virus in liver transplant recipients.
    Yoshida EM; Buczkowski AK; Giulivi A; Zou S; Forrester LA
    Liver Transpl; 2001 Jun; 7(6):521-5. PubMed ID: 11443581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
    Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
    Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation.
    Staatz CE; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of clinical safety of conversion to Advagraf therapy in liver transplant recipients: observational study.
    Marin-Gomez LM; Gomez-Bravo MA; Alamo-Martinez JA; Barrera-Pulido L; Bernal Bellido C; Suárez Artacho G; Pascasio JM
    Transplant Proc; 2009; 41(6):2184-6. PubMed ID: 19715867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection.
    Jain A; Vekatramanan R; Yelochan B; Kashyap R; Marcos A; Fung J
    Transplant Proc; 2005 Sep; 37(7):3190-6. PubMed ID: 16213346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients.
    Haririan A; Hamze O; Drachenberg CB; Ramos E; Weir MR; Klassen DK
    Transplantation; 2003 Apr; 75(8):1186-90. PubMed ID: 12717201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
    Villamil F; Levy G; Grazi GL; Mies S; Samuel D; Sanjuan F; Rossi M; Lake J; Munn S; Mühlbacher F; Leonardi L; Cillo U
    Transplant Proc; 2006 Nov; 38(9):2964-7. PubMed ID: 17112875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
    Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.